Bristol Myers Squibb's chief medical officer, Samit Hirawat, is leaving the drugmaker to pursue new professional opportunities.

Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...

Absci's shares were under pressure Friday after the clinical-stage biopharmaceutical priced a roughly $50 million stock offering to help fund the advancement of its internally developed programs and ...

The S&P 500 and Nasdaq Composite ended at record highs on Thursday (July 24), supported by stronger-than-expected earnings ...

IBM's stock (IBM) had been on a recent rally, outperforming the S&P 500 and other Big Tech stocks so far this year and trading at more than 24 times forward earnings, setting the company up with "some ...

DWS, a leading European asset manager with global reach, today announced the launch of the Xtrackers S&P 500 Diversified Sector Weight ETF (NASDAQ: SPXD) (the "Fund"), expanding its suite of ...

The quantum computing sector has a new fan on Wall Street, as Canaccord Genuity became the latest to recommend a stock in the ...

The successor to the first stock market index is getting up there with the S&P 500 and the Nasdaq Composite in all-time-high ...

Cap Value offers strong value exposure, sector diversification, and defensive traits. Click here to read an analysis of SCHV ...

DIAX writes options on a portfolio of constituents of the Dow Jones index and makes it possible to collect a higher yield than average. See why the Fund is a Buy.

There are about $10.5 billion of biotech convertibles outstanding, roughly 3% of the $305 billion market, according to BofA Securities.

Northrop Grumman is positioned to capitalize on international demand, in the Middle East and Europe, fueled by regional ...